Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
- PMID: 27536634
- PMCID: PMC4972797
- DOI: 10.5371/hp.2015.27.4.258
Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
Abstract
Purpose: This study was designed to investigate the effect of bisphosphonate administration starting time on bone healing and to identify the best administration time following surgical treatment of osteoporotic intertrochanteric fractures.
Materials and methods: Two hundreds and eighty four patients (284 hips; 52 males, 232 females) who underwent surgery following osteoporotic intertrochanteric fracture from December 2002 to December 2012 were retrospectively analyzed. The average follow-up period was 68.4 months. The patients were divided into three groups according to the time of bisphosphonate administration after operation: 1 week (group A; n=102), 1 month (group B; n=89), and 3 months (group C; n=93). Koval scores and change of Koval scores 1 year after operation were used for clinical evaluation. For radiologic evaluation, the time of callus appearance across the fracture line on sagittal and coronal radiographs and the time to absence of pain during hip motion was judged as the time of bone union.
Results: Koval scores one year after surgery for groups A, B, and C were 2.44, 2.36, and 2.43 (P=0.895), respectively. The mean time of union was 12.4, 11.9, and 12.3 weeks after operation in the three groups (P=0.883), respectively. There were zero cases of nonunion. There were 3, 5, and 7 cases of fixative displacement in the three groups, respectively, but the distribution showed no significant difference (P>0.472).
Conclusion: The initiating time of bisphosphonate administration following surgery does not affect the clinical outcomes in patients with osteoporotic intertrochanteric fracture.
Keywords: Bisphosphonates; Bone healing; Intertrochanteric fractures; Osteoporotic fractures.
Figures


Similar articles
-
Effect of Preoperative Bisphosphonate Treatment on Fracture Healing after Internal Fixation Treatment of Intertrochanteric Femoral Fractures.Hip Pelvis. 2019 Jun;31(2):75-81. doi: 10.5371/hp.2019.31.2.75. Epub 2019 May 30. Hip Pelvis. 2019. PMID: 31198773 Free PMC article.
-
Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?J Bone Joint Surg Br. 2012 Jul;94(7):956-60. doi: 10.1302/0301-620X.94B7.29079. J Bone Joint Surg Br. 2012. PMID: 22733953 Clinical Trial.
-
Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures.Clin Orthop Surg. 2016 Dec;8(4):437-443. doi: 10.4055/cios.2016.8.4.437. Epub 2016 Nov 4. Clin Orthop Surg. 2016. PMID: 27904727 Free PMC article.
-
Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures.J Bone Joint Surg Am. 2012 Oct 3;94(19):1729-36. doi: 10.2106/JBJS.K.01434. J Bone Joint Surg Am. 2012. PMID: 22992762 Clinical Trial.
-
Effects of Zoledronic Acid Treatment on Fracture Healing, Morbidity and Mortality in Elderly Patients with Osteoporotic Hip Fractures.Strategies Trauma Limb Reconstr. 2019 Sep-Dec;14(3):126-131. doi: 10.5005/jp-journals-10080-1439. Strategies Trauma Limb Reconstr. 2019. PMID: 32742427 Free PMC article.
Cited by
-
The effect of osteoporosis and its treatment on fracture healing a systematic review of animal and clinical studies.Bone Rep. 2021 Aug 16;15:101117. doi: 10.1016/j.bonr.2021.101117. eCollection 2021 Dec. Bone Rep. 2021. PMID: 34458509 Free PMC article. Review.
-
Effect of Preoperative Bisphosphonate Treatment on Fracture Healing after Internal Fixation Treatment of Intertrochanteric Femoral Fractures.Hip Pelvis. 2019 Jun;31(2):75-81. doi: 10.5371/hp.2019.31.2.75. Epub 2019 May 30. Hip Pelvis. 2019. PMID: 31198773 Free PMC article.
-
The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.Osteoporos Int. 2024 Nov;35(11):1897-1907. doi: 10.1007/s00198-024-07191-5. Epub 2024 Aug 8. Osteoporos Int. 2024. PMID: 39115687 Free PMC article.
References
-
- Murakami H, Takahashi N, Sasaki T, et al. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders. Bone. 1995;17:137–144. - PubMed
-
- Sato M, Grasser W. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res. 1990;5:31–40. - PubMed
-
- Bartl R. Update 2004. Osteoporosis--management--current status. Krankenpfl J. 2004;42:232. - PubMed
-
- Shin CS, Choi HJ, Kim MJ, et al. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone. 2010;47:378–387. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources